Submit Deal

ENDO INTERNATIONAL

HQ - Malvern

Summary

Endo is an American diversified pharmaceutical company.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 5.17 B

Avg. Deal Size£ 5.17 B

Market Context

Senior Management

Scott Hirsch
Interim CEO
Juan Avendano
Senior Director, Investor Relations
Linda Huss
Senior Director, Corporate Communications

Sort

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 5.17 B

Total Value

davis polk & wardwell

HQ - New York

legal advisors (1)

1 Shared Deal

1 For

£ 5.17 B

Total Value

paul weiss rifkind wharton & garrison

HQ - New York

legal advisors (1)

1 Shared Deal

1 For

£ 5.17 B

Total Value

a&l goodbody

HQ - Dublin, Ireland

legal advisors (1)

1 Shared Deal

1 For

£ 5.17 B

Total Value

lazard

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 5.17 B

Total Value

joele frank

HQ - New York

pr advisors (1)

1 Shared Deal

1 Opposite

£ 5.17 B

Total Value

arthur cox

HQ - Dublin, Ireland

legal advisors (1)

1 Shared Deal

1 Opposite

£ 5.17 B

Total Value

wachtell lipton rosen & katz

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 5.17 B

Total Value

hogan lovells

HQ - London

legal advisors (1)

1 Shared Deal

1 Opposite

£ 5.17 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy